PREDICTION OF OVARIAN RESPONSE BY ANTI-MULLERIAN HORMONE IN WOMEN WITH PCOS
Journal Title: Journal of Evidence Based Medicine and Healthcare - Year 2018, Vol 5, Issue 4
Abstract
BACKGROUND AMH would hinder the effect of FSH and participate in the pathogenesis of PCOS. This proof has led to hypothesise that there is a subgroup of women suffering from PCOS who have the excessive levels of AMH and who are the more resistant to gonadotropins therapy. The aim of the study was to evaluate the serum AMH levels in predicting ovarian response in infertile women with PCOS. MATERIALS AND METHODS This study was a prospective study conducted in Laxmi Narasimha Hospital, Warangal Telangana, for a period of 2 years from January 2014 to February 2016. Totally, 200 women who were admitted in infertility clinic and having induction of ovulation by gonadotropins. The patients were divided into two groups- namely, Group A, which included 100 patients who were women with PCOS having anti-Mullerian hormone <7.77 mg/dL, Group B which included 100 patients who were women with PCOS having anti-Mullerian hormone >7.77 mg/dL. RESULTS Body mass index in kg/m2 of 27.3 ± 3.2 in group A, 27.8 ± 1.5 in group B and the ‘p’ value was nonsignificant, duration of infertility in minutes of 8.0 ± 1.8 in group A, 8.4 ± 2.7 in group B and the ‘p’ value was nonsignificant, number of developing follicles at insemination of 3.2 ± 1.4 in group A, 3.7 ± 1.2 in group B and the ‘p’ value was nonsignificant, mean diameter of dominant follicles at insemination of 22.3 ± 1.1 in group A, 21.0 ± 1.8 in group B and the ‘p’ value was nonsignificant. Biochemical pregnancy rates were 4411.2 in group A, 3122.5 in group B, clinical pregnancy rates were 3022.8 in group A and 2478.1 in group B, dose of HMG (IU/cycle) was 658 ± 35.8 in group A and 820.9 ± 54.9 in group B. AMH sensitivity, specificity, PPV, NPV, accuracy and diagnostic odds ratio was 62, 90, 65, 80, 71.8, 18.25, respectively when threshold concentration was 7.77 ng/mL. CONCLUSION In outcome prediction, circulating serum AMH level evaluation for anovulatory women suffering from PCOS before undergoing therapy acts as a helpful tool. It can act in predicting ovarian response in inducing gonadotropins therapy.
Authors and Affiliations
Burri Sandhya Rani
Keywords
Related Articles
- EP ID EP450957
- DOI 10.18410/jebmh/2018/66
- Views 70
- Downloads 0
ACQUIRED CUTIS LAXA WITH RECURRENT URTICARIA
A 30 year old male patient presented with progressive laxity and wrinkling of skin over the face for past 10 years, patient also gives history of recurrent urticaria since 12 years. Skin biopsy using Verhoff Van Gieson s...
IMPACT OF VITAMIN D ON PREGNANCY AND PREGNANCY OUTCOME
Vitamin D is required throughout life. It is necessary for the formation of bone, but also likely plays an important role in several other physiological systems and it prevents several degenerative diseases and anticance...
EFFICACY OF MIFEPRISTONE IN REDUCING THE SIZE OF FIBROIDS
BACKGROUND Uterine leiomyomata are the commonest benign gynaecological tumours occurring in up to 25 per cent of women in reproductive age. There are various surgical and medical modalities of treatment of fibroids which...
A CLINICAL STUDY ON EXTRA CRANIAL COMPLICATIONS OF CHRONIC SUPPURATIVE OTITIS MEDIA
OBJECTIVES: The Objective is to study the risk of extra-cranial complications in cases of CSOM and to study the common extra-cranial complications of CSOM with respect to age, sex and socio-economic status. METHODS: The...
A PROSPECTIVE STUDY OF SKIN MANIFESTATIONS IN CHRONIC KIDNEY DISEASES
BACKGROUND: Skin disorders associated with chronic kidney disease (CKD) can markedly affect a patient’s quality of life and can negatively impact their mental and physical health. OBJECTIVES: The purpose of this prospect...